Alvotech And Teva File US Stelara Rival Ahead Of 2023 Expiry

Filing For AVT04 Proposed Ustekinumab Biosimilar Is Accepted By US FDA

Sign outside of FDA's headquarters in White Oak, MD
Alvotech’s Stelara biosimilar has been filed with the FDA • Source: Alamy

More from Biosimilars

More from Products